Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LataMed AILMED -5.52%23 Debt-to-Equity is 0.07 as of Jun. 2026. GuruFocus rates LMED with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 2,247 Software companies, LataMed AI ranks better than 72.72% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for LataMed AI's Debt-to-Equity or its related term are showing as below:
LMED'
s Debt-to-Equity Range Over the Past 10 Years
Min: -0.7 Med: -0.6 Max: 0.07
Current: 0.07
During the past 3 years, the highest Debt-to-Equity Ratio of LataMed AI was 0.07. The lowest was -0.70. And the median was -0.60.
LMED's Debt-to-Equity is ranked better than 72.72% of 2247
companies
in the Software industry
Industry Median: 0.2
vs LMED: 0.07
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
LataMed AI Debt-to-Equity Related Terms
LataMed AI Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for LataMed AI's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LMED vs RYDE, RDZN, DMRC: Debt-to-Equity Comparison
For the Software - Application subindustry, LataMed AI's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LataMed AI Debt-to-Equity vs Software Industry
For the Software industry and Technology sector, LataMed AI's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where LataMed AI's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LataMed AI (LMED) has a Debt-to-Equity of 0.07 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on LataMed AI and its competitors. According to the industry distribution chart, LataMed AI ranks #613 out of 2247 companies in the Software industry, placing it in the top 27.3%.
Is LataMed AI's Debt-to-Equity too high?
LataMed AI's current Debt-to-Equity is 0.07. The Software industry median Debt-to-Equity is 0.20. LataMed AI's value of 0.07 is 65% below this industry median. Based on the distribution chart, LataMed AI ranks #613 out of 2247 companies in the Software industry, which is above the industry midpoint. Overall, LataMed AI has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does LataMed AI's Debt-to-Equity compare to RYDE and RDZN?
According to the Software industry distribution chart, LataMed AI ranks #613 out of 2247 companies for Debt-to-Equity. This puts LataMed AI in the upper half of its industry. The industry median Debt-to-Equity is 0.20. LataMed AI's value of 0.07 is 65% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Software company?
The median Debt-to-Equity among Software companies is 0.20, based on 2,247 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LataMed AI's current Debt-to-Equity of 0.07 is 65% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on LataMed AI and its competitors. For the Software industry, the median Debt-to-Equity is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LataMed AI's current Debt-to-Equity is 0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LataMed AI stock overvalued right now?
LataMed AI (LMED) has a current Debt-to-Equity of 0.07. The current Debt-to-Equity is 0.07 and 65% below the Software industry median of 0.20. LataMed AI's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For LataMed AI (LMED), the current Debt-to-Equity is 0.07 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
LataMed AI Corp is a technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions across Latin America. Its healthcare platform includes AI-enabled analytics, telehealth infrastructure, and coordinated care systems designed to support healthcare delivery in emerging markets. The company develops digital infrastructure for patient prioritization, clinical workflow management, telehealth access, care coordination, and healthcare system operations. It holds issued patents for its core AI modules-CardioAI, PulmoAI, and NeuroAI-which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management.
23GF Score
Get the complete analysis for LMED
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMED has been successfully added to your 
